PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
PRVL
Delisted
PRVL was delisted on the 21st of January, 2021.
38 hedge funds and large institutions have $349M invested in Prevail Therapeutics Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+38
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
38
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$182M |
| 2 |
RCM
2
RA Capital Management
Boston,
Massachusetts
|
$36.2M |
| 3 |
EC
3
EcoR1 Capital
San Francisco,
California
|
$31.6M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$15.7M |
| 5 |
BC
5
Boxer Capital
San Diego,
California
|
$14.8M |
Top Sellers
No sellers this quarter
